HK Stock Market Move | MEDBOT-B(02252) has risen more than 8% again, with a cumulative total of orders exceeding 100 units. The company's internationalization process will accelerate.

MEDBOT-B (02252) rose by over 8%, as of the latest update, it was up by 6.75% to 12.66 Hong Kong dollars, with a trading volume of 91.992 million Hong Kong dollars. On the news front, Siasun Robot&Automation recently disclosed that the company's comprehensive order volume has exceeded 100 units, with 39 global orders for the 2024 Tumor Siasun Robot&Automation, commercial installations surpassing 30 units, and nearly 60 cumulative commercial orders worldwide, indicating rapid growth in international business. In addition, in 2024, Honghu Siasun Robot&Automation received 25 global orders, with cumulative orders exceeding 40 units; and R-ONE became the only domestic coronary intervention surgery Siasun Robot&Automation product to be listed and sold. It is worth noting that on November 16, 2024, at the headquarters of Micro-Surgery Siasun Robot&Automation, a French surgical expert used the Tumor Siasun Robot&Automation to perform remote surgery on a patient in Casablanca, Morocco, through the global remote command center of Siasun Robot&Automation. He Chao, President of Micro-Surgery Siasun Robot&Automation Group, stated that this was another major breakthrough following the remote surgery assistance for Shanghai to Benin in October 2024, marking the entry of Tumor Siasun Robot&Automation into the "1 to 10" development stage, and the internationalization process will accelerate.